Examkin

Patient Management

2074 soru

Tüm türler2,074Çoktan seçmeli1,048Çoklu seçim393Eşleştirme221Sıralama412
Soru 1821Soru →

A 4242-year-old man comes to the clinic for a follow-up evaluation of elevated blood pressure. During his last visit three months ago, his blood pressure was 152/94 mmHg152/94 \text{ mmHg}, and he was advised to initiate a low-sodium diet and start an exercise program. Today, his blood pressure is 156/96 mmHg156/96 \text{ mmHg}. His heart rate is 72 /min72\text{ /min}. The physical examination is unremarkable. The patient has a 55-year history of bipolar I disorder that has been well controlled with lithium monotherapy. He takes no other medications. Laboratory studies show a serum creatinine of 0.9 mg/dL0.9 \text{ mg/dL}, serum sodium of 140 mEq/L140 \text{ mEq/L}, and a serum lithium level of 0.8 mEq/L0.8 \text{ mEq/L} (therapeutic range: 0.6−1.2 mEq/L0.6-1.2 \text{ mEq/L}). The physician decides to start pharmacotherapy for primary hypertension. Which of the following is the most appropriate medication for this patient?

Cevabı ve açıklamayı göster

Cevap: Amlodipine

Cevap

Amlodipine
The correct answer is amlodipine. This patient requires pharmacologic treatment for primary hypertension. Standard first-line agents include thiazide diuretics, angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARBs), and calcium channel blockers (CCBs). However, this patient is taking lithium, which has a narrow therapeutic index and is almost entirely excreted by the kidneys. Lithium reabsorption is closely linked to sodium handling in the proximal convoluted tubule. Thiazide diuretics, ACE inhibitors, ARBs, and nonsteroidal anti-inflammatory drugs (NSAIDs) all significantly decrease renal lithium clearance, potentially precipitating severe neurotoxicity. Dihydropyridine CCBs, such as amlodipine, do not significantly affect renal lithium handling and represent the safest first-line choice for this patient.

Adım Adım Çözüm

1
Identify the patient's new diagnosis and therapeutic requirement.
The patient has stage 2 primary hypertension requiring initiation of first-line antihypertensive pharmacotherapy.
Blood pressure remains elevated (>140/90 mmHg>140/90 \text{ mmHg}) despite a 3-month trial of lifestyle modifications.
2
Review the patient's comorbidities and current medication list for potential interactions.
The patient has bipolar I disorder and is stable on lithium monotherapy.
Lithium has a narrow therapeutic index and its serum levels are heavily dependent on renal clearance.
3
Evaluate standard first-line antihypertensives (thiazides, ACE inhibitors, ARBs, CCBs) for safety in the context of lithium therapy.
Thiazides, ACE inhibitors, and ARBs profoundly decrease renal lithium clearance. CCBs do not.
Avoiding iatrogenic lithium toxicity dictates the choice of the antihypertensive agent.
4
Select the most appropriate pharmacologic intervention.
Amlodipine is chosen.
It is a first-line agent for primary hypertension that does not interfere with renal lithium handling.

Anahtar Kavram

In patients taking lithium, first-line antihypertensives such as thiazide diuretics, ACE inhibitors, and ARBs must be avoided due to their ability to decrease renal lithium clearance and cause severe toxicity. Calcium channel blockers are the safest first-line alternative.
Soru 1822Soru →

A 5252-year-old man is evaluated in the hospital for new-onset right flank pain and gross hematuria. He was admitted 66 days ago for the treatment of a proximal deep vein thrombosis of the left lower extremity. His past medical history is significant for a mechanical aortic valve replacement 55 years ago, for which he takes warfarin. On admission, his international normalized ratio (INR) was 1.21.2 due to several missed doses. He was started on a therapeutic dose of subcutaneous enoxaparin, and his home dose of warfarin was restarted.

Current vital signs are: temperature is 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}), blood pressure is 138/86 mm Hg138/86\text{ mm Hg}, pulse is 98/min98\text{/min}, and respirations are 16/min16\text{/min}. Physical examination shows right costovertebral angle tenderness. The left lower extremity edema is unchanged.

Laboratory results today show:
Platelet count: 95,000/mm395,000\text{/mm}^3 (Admission: 220,000/mm3220,000\text{/mm}^3)
Creatinine: 1.1 mg/dL1.1\text{ mg/dL}
INR: 1.81.8

A CT venogram of the abdomen and pelvis confirms a right renal vein thrombosis.

Which of the following is the most appropriate next step in pharmacologic management?

Cevabı ve açıklamayı göster

Cevap: Discontinue enoxaparin, discontinue warfarin, administer vitamin K, and initiate intravenous argatroban

Cevap

Discontinue enoxaparin, discontinue warfarin, administer vitamin K, and initiate intravenous argatroban
This patient has developed Heparin-Induced Thrombocytopenia (HIT) complicated by a new thrombosis (renal vein thrombosis). HIT is diagnosed by a >50%>50\% drop in platelets (from 220,000/mm3220,000\text{/mm}^3 to 95,000/mm395,000\text{/mm}^3) typically occurring 55 to 1010 days after heparin exposure. The correct pharmacologic management requires three immediate steps: 1) Discontinuation of all heparin products (enoxaparin). 2) Initiation of a non-heparin anticoagulant, such as a direct thrombin inhibitor (argatroban, bivalirudin) or fondaparinux, to manage the intense hypercoagulable state. 3) Discontinuation and reversal of warfarin with vitamin K. Warfarin rapidly depletes the natural anticoagulant Protein C (which has a short half-life). In a patient with HIT, this creates a severe procoagulant imbalance that commonly leads to venous limb gangrene. Therefore, warfarin must be stopped and reversed until the platelet count recovers to at least 150,000/mm3150,000\text{/mm}^3.

Adım Adım Çözüm

1
Diagnose Heparin-Induced Thrombocytopenia (HIT).
The patient has a >50%>50\% drop in platelets occurring on day 66 of enoxaparin exposure, combined with a new thrombotic event.
Recognizing the 4T score criteria is required before altering the pharmacologic regimen.
2
Stop all heparin products immediately.
Enoxaparin (low-molecular-weight heparin) must be discontinued.
Continued exposure to heparin fuels the formation of IgG antibodies against platelet factor 4 (PF4)-heparin complexes, worsening thrombosis.
3
Select an alternative non-heparin anticoagulant.
Intravenous argatroban (a direct thrombin inhibitor) is chosen.
Patients with HIT are in an intensely hypercoagulable state. Stopping heparin is not enough; immediate alternative anticoagulation is required to treat the new renal vein thrombosis.
4
Address the concurrent warfarin therapy.
Warfarin must be discontinued AND reversed with vitamin K.
Warfarin rapidly depletes Protein C (a natural anticoagulant). In the setting of the massive procoagulant response of HIT, this severe imbalance causes microvascular thrombosis and venous limb gangrene.

Anahtar Kavram

Management of Heparin-Induced Thrombocytopenia (HIT) with thrombosis, specifically the requirement to reverse concurrent warfarin therapy to prevent venous limb gangrene.
Tahmini Süre:2m 0s
Soru 1823Soru →

A 6262-year-old man is evaluated in the intensive care unit for new-onset confusion, dizziness, and unsteady gait. He was admitted 55 days ago for severe community-acquired pneumonia complicated by acute respiratory distress syndrome and acute kidney injury. His medical history is significant for generalized epilepsy, for which he takes phenytoin 300 mg300\text{ mg} daily. Over the past 2424 hours, he has become increasingly lethargic and complains of double vision. Physical examination reveals prominent bidirectional horizontal nystagmus and severe ataxia.

Laboratory studies show:
- Serum creatinine: 4.2 mg/dL4.2\text{ mg/dL} (baseline 1.1 mg/dL1.1\text{ mg/dL})
- Blood urea nitrogen: 78 mg/dL78\text{ mg/dL}
- Serum albumin: 2.2 g/dL2.2\text{ g/dL}
- Total serum phenytoin: 14 mcg/mL14\text{ mcg/mL} (therapeutic range: 10-20 mcg/mL10\text{-}20\text{ mcg/mL})

Which of the following is the most appropriate next step in evaluating and managing this patient's neurologic symptoms?

Cevabı ve açıklamayı göster

Cevap: Obtain a free serum phenytoin concentration

Cevap

Obtain a free serum phenytoin concentration.
The correct answer is to obtain a free serum phenytoin concentration. Phenytoin is a highly protein-bound medication, with approximately 90%90\% bound to serum albumin under normal conditions. The standard laboratory measurement for phenytoin is a total serum level, which includes both the protein-bound and the unbound (free) drug. Because only the free drug is pharmacologically active and capable of crossing the blood-brain barrier to cause toxicity, evaluating the free level is critical in specific populations. In patients with significant hypoalbuminemia (less binding capacity) or acute kidney injury/uremia (where accumulated uremic toxins competitively displace phenytoin from albumin), the fraction of free phenytoin increases substantially. In such scenarios, a 'normal' total phenytoin level (e.g., 14 mcg/mL14\text{ mcg/mL}) can dangerously mask a toxic free phenytoin concentration. This patient exhibits classic signs of phenytoin toxicity, including altered mental status, horizontal nystagmus, and severe ataxia. Given his renal failure and low albumin, assessing the free phenytoin level is the essential next step to confirm toxicity and guide a required dose reduction.

Adım Adım Çözüm

1
Analyze the patient's clinical presentation.
The patient demonstrates lethargy, bidirectional nystagmus, diplopia, and ataxia.
These are the classic, hallmark signs of acute phenytoin toxicity.
2
Evaluate the laboratory results in the context of the patient's comorbidities.
The total phenytoin level appears normal (14 mcg/mL14\text{ mcg/mL}), but the patient has severe hypoalbuminemia (2.2 g/dL2.2\text{ g/dL}) and acute kidney injury with uremia (BUN 78 mg/dL78\text{ mg/dL}).
Severe renal failure and low albumin significantly alter the pharmacokinetics of highly protein-bound drugs.
3
Determine the pharmacokinetic effect of the comorbidities on the medication.
Hypoalbuminemia provides fewer binding sites, and uremic toxins competitively inhibit drug binding to albumin.
This combination leads to a higher fraction of unbound, pharmacologically active (free) phenytoin in the serum, causing clinical toxicity despite a 'normal' total level.
4
Select the appropriate management step.
The most appropriate next step is to obtain a free serum phenytoin concentration.
This will definitively quantify the suspected toxicity and appropriately guide subsequent dose reduction.

Anahtar Kavram

In patients with hypoalbuminemia or uremia, total serum phenytoin levels may appear falsely normal while the biologically active free fraction is in the toxic range; proper evaluation requires measuring free serum phenytoin levels.
Soru 1824Soru →

A 28-year-old nulliparous woman at 28 weeks gestation presents to the obstetric clinic for a routine prenatal evaluation. Her pregnancy has been entirely uncomplicated to date, and she reports normal fetal movement. Her vital signs are within normal limits. She had a normal 1-hour 50-g oral glucose challenge test at her 26-week visit. Laboratory testing from her first trimester showed she is blood type A positive, non-immune to rubella, non-immune to varicella, and negative for HIV, syphilis, and hepatitis B and C. She received an inactivated influenza vaccine at 12 weeks gestation. She has no significant past medical history and takes a daily prenatal vitamin. Which of the following is the most appropriate next step in preventive care for this patient today?

Cevabı ve açıklamayı göster

Cevap: Administer the tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine

Cevap

The most appropriate next step is to administer the tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
The correct answer is to administer the tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine. The Advisory Committee on Immunization Practices (ACIP) and the American College of Obstetricians and Gynecologists (ACOG) recommend administering the Tdap vaccine during every pregnancy, regardless of the patient's prior vaccination history. The optimal timing for administration is between 27 and 36 weeks of gestation. This specific timing window maximizes the maternal antibody response and facilitates the passive transfer of protective IgG antibodies across the placenta. This passive immunity is crucial because it protects the infant from pertussis (whooping cough) during the vulnerable first few months of life, before the infant is old enough to receive their own primary vaccination series. Since this healthy patient is currently at 28 weeks gestation, it is the ideal time to administer the Tdap vaccine.

Adım Adım Çözüm

1
Evaluate the patient's current gestational age and prior screening history.
The patient is at 28 weeks gestation, is Rh(D) positive, has already completed gestational diabetes screening, and is non-immune to rubella and varicella.
Establishing the patient's baseline is necessary to determine which prenatal preventive interventions are indicated at the current visit.
2
Apply evidence-based prenatal preventive care guidelines for the early third trimester.
Routine care optimally between 27 and 36 weeks of gestation includes the administration of the Tdap vaccine.
Guidelines mandate Tdap administration in every pregnancy to maximize the passive transfer of protective pertussis antibodies to the fetus.
3
Rule out alternative interventions by assessing absolute contraindications and indication criteria.
The MMR vaccine is contraindicated due to pregnancy, Rh(D) immune globulin is not indicated due to Rh-positive status, and group B streptococcus screening is premature.
This confirms that Tdap vaccination is the only correct and safe preventive intervention among the choices provided.

Anahtar Kavram

The tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine is recommended for all pregnant women during every pregnancy, optimally between 27 and 36 weeks of gestation, regardless of prior vaccination history.
Soru 1825Soru →

A 42-year-old female presents to the outpatient clinic reporting progressive joint pain, increased sweating, and noticing that her shoe size has increased over the past two years. She also mentions having to resize her wedding ring twice recently due to her fingers becoming "too thick." Her past medical history is significant for newly diagnosed hypertension and type 2 diabetes mellitus, which are currently managed with amlodipine and metformin. Vital signs include a blood pressure of 148/92 mmHg, a heart rate of 78/min, and a BMI of 29 kg/m^2. Physical examination reveals a prominent jaw, a visibly enlarged tongue, and coarse facial features. Her hands are notably fleshy with broadened fingers. Which of the following is the most appropriate initial step in the diagnostic workup?

Cevabı ve açıklamayı göster

Cevap: Measurement of serum insulin-like growth factor 1 level

Cevap

Measurement of serum insulin-like growth factor 1 level
The correct initial diagnostic step for a patient presenting with classic signs of acromegaly (acral overgrowth, coarse facial features, and metabolic derangements) is the measurement of insulin-like growth factor 1 (IGF-1). Because growth hormone is secreted in a pulsatile manner, a single random measurement is unreliable. IGF-1 provides a stable, integrated measure of growth hormone secretion over time, making it the most sensitive initial screening test.

Adım Adım Çözüm

1
Identify the underlying clinical syndrome based on the patient's presentation.
The combination of acral overgrowth (increasing shoe and ring size), coarse facial features, macroglossia, hyperhidrosis, and newly diagnosed metabolic conditions (hypertension, diabetes mellitus) strongly points to a diagnosis of acromegaly.
Recognizing the constellation of symptoms is essential before initiating the diagnostic pathway.
2
Recall the diagnostic algorithm and proper test sequencing for suspected acromegaly.
The correct sequence is: biochemical screening, followed by biochemical confirmation, and finally anatomical localization.
Adhering to evidence-based sequencing avoids false positives from premature imaging and incorrect interpretations from volatile biomarkers.
3
Select the appropriate initial screening test for the sequence.
Insulin-like growth factor 1 (IGF-1) is the correct choice, as its stable serum concentration directly correlates with overall growth hormone activity.
Direct growth hormone measurement is unreliable due to pulsatile secretion, making IGF-1 the most accurate and cost-effective initial step.

Anahtar Kavram

The diagnostic workup for suspected acromegaly begins with a screening serum insulin-like growth factor 1 (IGF-1) level, followed by a confirmatory oral glucose suppression test if the IGF-1 is elevated, and concluding with a pituitary MRI for anatomical localization.
Soru 1826Soru →

A 32-year-old woman is evaluated in the emergency department after experiencing a sudden onset of right-sided pleuritic chest pain and a mild dry cough that began 12 hours ago. She has no significant past medical history other than taking combined oral contraceptives. She works as a software engineer and lives in a ground-floor apartment with her spouse. Vital signs show a temperature of 37.1°C (98.8°F), blood pressure of 122/78 mm Hg, heart rate of 86/min, respiratory rate of 16/min, and oxygen saturation of 97% on room air. Physical examination reveals clear lungs bilaterally, normal heart sounds without murmurs or gallops, and mild right calf tenderness. Laboratory studies, including a complete blood count and comprehensive metabolic panel, are within normal limits. Cardiac troponin and N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels are undetectable. A CT pulmonary angiogram confirms a small acute segmental pulmonary embolism in the right lower lobe. Bedside echocardiography demonstrates a normal-sized right ventricle with normal systolic function. She is reliable, understands her diagnosis, and expresses a strong preference to avoid hospitalization if possible. Which of the following is the most appropriate disposition for this patient?

Cevabı ve açıklamayı göster

Cevap: Discharge home from the emergency department with a prescription for a direct oral anticoagulant

Cevap

Discharge home from the emergency department with a prescription for a direct oral anticoagulant
This patient meets all established clinical criteria for the outpatient management of an acute pulmonary embolism. Her simplified Pulmonary Embolism Severity Index (sPESI) score is 0 because she is younger than 80, has no history of cancer or chronic cardiopulmonary disease, and maintains a heart rate < 110/min, systolic blood pressure ≥ 100 mm Hg, and oxygen saturation ≥ 90%. Furthermore, she has no evidence of right ventricular strain on echocardiography and normal cardiac biomarkers, securing her classification in the low-risk category. Combined with her reliable social support, independence, and lack of bleeding contraindications, the standard of care is to bypass inpatient admission entirely and discharge her home from the emergency department with a direct oral anticoagulant (e.g., apixaban or rivaroxaban).

Adım Adım Çözüm

1
Calculate the patient's objective risk score using the Pulmonary Embolism Severity Index (PESI) or simplified PESI (sPESI).
The patient's sPESI score is 0, as she is under 80 years old with no cancer, no chronic cardiopulmonary disease, normal heart rate, normal systolic blood pressure, and normal oxygen saturation.
Risk stratification is the first step in determining the appropriate disposition for a patient with a newly diagnosed pulmonary embolism.
2
Assess for signs of right ventricular strain or myocardial necrosis.
Both the bedside echocardiogram and cardiac biomarkers (troponin, NT-proBNP) are normal.
The presence of right heart strain or necrosis would upgrade the risk category to intermediate, necessitating hospital admission.
3
Evaluate the patient's functional capacity and social support system.
The patient is independent, lives with a supportive spouse, and has strong health literacy.
Safe outpatient management requires that the patient can reliably obtain and administer medications and return to the hospital if symptoms worsen.
4
Determine the final care setting based on the synthesized data.
The patient is safely discharged directly home with a direct oral anticoagulant (DOAC).
Clinical guidelines strongly recommend outpatient management for carefully selected, hemodynamically stable, low-risk patients with acute pulmonary embolism.

Anahtar Kavram

Hemodynamically stable patients with acute pulmonary embolism who are low-risk (e.g., sPESI of 0), lack right ventricular strain, and have good social support should be discharged home directly from the emergency department on a direct oral anticoagulant.
Soru 1827Soru →

A 45-year-old man with a history of alcohol use disorder and traumatic brain injury is brought to the emergency department with continuous generalized tonic-clonic convulsions. Paramedics report that the seizure began 20 minutes ago and has not ceased. His current medication list includes levetiracetam, which his family states he has not taken for a week, and a daily multivitamin.

Physical examination reveals a completely unresponsive patient with rhythmic, violent muscle contractions of all four extremities. Vital signs are temperature 37.8°C (100.0°F), blood pressure 150/90 mmHg, heart rate 130/min, and oxygen saturation 94% on a non-rebreather mask.

Pertinent laboratory findings:
Capillary blood glucose: 105 mg/dL
Serum sodium: 138 mEq/L
Serum calcium: 9.2 mg/dL

Arrange the following pharmacologic interventions in the correct algorithmic sequence for the progressive management of this patient's status epilepticus, starting with the initial first-line therapy and ending with the treatment for super-refractory disease.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence for managing status epilepticus is: 1) Intravenous lorazepam, 2) Intravenous fosphenytoin, 3) Intravenous propofol infusion, 4) Intravenous pentobarbital infusion.
The correct sequence for managing status epilepticus follows a strict time-based algorithm to balance rapid seizure termination with the prevention of respiratory and hemodynamic collapse. First-line therapy requires an immediate, rapid-acting benzodiazepine (intravenous lorazepam) to halt active convulsions. Once the active seizure is addressed, a second-line, longer-acting antiseizure medication (intravenous fosphenytoin) is administered to provide sustained seizure control. If seizures persist despite these interventions (refractory status epilepticus), the patient is escalated to third-line therapy with continuous anesthetic infusions (intravenous propofol), which necessitates endotracheal intubation. Finally, if the patient continues to seize despite anesthetic infusions (super-refractory status epilepticus), fourth-line therapy with a profound barbiturate coma (intravenous pentobarbital) is initiated.

Adım Adım Çözüm

1
Identify the patient's condition as status epilepticus.
The patient has had continuous seizures for 20 minutes, necessitating immediate, algorithmic pharmacologic escalation.
Status epilepticus is a neurologic emergency with high morbidity and mortality if not treated promptly in a stepwise manner.
2
Select the appropriate first-line therapy.
Intravenous lorazepam is administered immediately.
Benzodiazepines quickly penetrate the blood-brain barrier to potentiate GABA-A receptors and halt active clinical seizures.
3
Determine the necessary second-line therapy for sustained control.
Intravenous fosphenytoin is administered next.
Once the initial seizure is addressed, a long-acting non-anesthetic antiseizure medication is required to prevent recurrence without causing profound respiratory depression.
4
Identify the treatment for refractory status epilepticus if seizures continue.
Intravenous propofol infusion is selected as third-line therapy.
When standard medications fail, continuous anesthetic infusions are initiated, which mandate endotracheal intubation and mechanical ventilation.
5
Determine the final escalation step for super-refractory cases.
Intravenous pentobarbital infusion is reserved as fourth-line therapy.
Barbiturate comas carry severe risks (e.g., profound hypotension, ileus) and are only used when other continuous anesthetics fail to achieve burst suppression on EEG.

Anahtar Kavram

Algorithmic stepwise pharmacologic escalation in status epilepticus, prioritizing rapid seizure termination followed by sustained control and continuous anesthetic coma for refractory cases.
Soru 1828Soru →

A 68-year-old man with a 40-pack-year smoking history undergoes a routine chest radiograph prior to an elective inguinal hernia repair. The radiograph reveals an incidental 1.4-cm, somewhat spiculated, peripheral solitary pulmonary nodule in the right upper lobe. He is entirely asymptomatic, has no significant medical history, and takes no medications. Assuming all subsequent findings indicate the continuous need for further investigation, arrange the following diagnostic steps in the most appropriate chronological order from initial evaluation to definitive diagnostic confirmation.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence for evaluating an incidentally discovered solitary pulmonary nodule >8 mm is to first review previous chest imaging studies, followed by a non-contrast CT scan of the chest, then an FDG-PET scan, and finally a CT-guided percutaneous core needle biopsy.
The correct sequence adheres to the core principle of diagnostic parsimony and progressive risk stratification. Reviewing prior imaging is the safest, most cost-effective initial step to prove stability. A dedicated non-contrast CT is necessary for detailed anatomical characterization if prior imaging is absent or shows growth. For nodules >8 mm with suspicious features (like spiculation), a PET scan further risk-stratifies the lesion and stages the patient. Finally, invasive biopsy is performed only after non-invasive modalities confirm a high suspicion of malignancy and localize the safest, highest-yield target.

Adım Adım Çözüm

1
Assess chronicity by reviewing previous imaging.
Determines if the nodule is new, growing, or historically stable.
Stability over 24 months reliably excludes malignancy in most cases, preventing unnecessary radiation and invasive procedural risks.
2
Perform anatomical characterization using a non-contrast chest CT.
Provides high-resolution morphological data such as exact size, spiculation, fat containment, and calcification patterns.
CT features are essential for calculating the pre-test probability of malignancy and guiding the need for subsequent functional imaging or biopsy.
3
Conduct functional assessment and staging with an FDG-PET scan.
Evaluates the metabolic activity of the primary nodule and screens for regional nodal or distant metastatic disease.
PET is a highly sensitive test for nodules >8 mm that helps determine if the nodule is hypermetabolic (concerning for cancer) and selects the optimal biopsy site.
4
Obtain definitive histopathology via CT-guided biopsy.
Yields a physical tissue sample for microscopic evaluation.
Provides the necessary pathological confirmation of malignancy or specific infectious/inflammatory etiologies before surgical resection or oncologic therapy is initiated.

Anahtar Kavram

The evaluation of an incidental solitary pulmonary nodule utilizes a stepwise progression from least invasive assessments (prior imaging) to high-resolution anatomical imaging (CT), followed by functional imaging (PET) for risk stratification, and culminating in invasive tissue sampling (biopsy) only when clinically indicated.
Soru 1829Soru →

A 2929-year-old woman is brought to the emergency department by her husband due to severe agitation, confusion, and a pounding heartbeat. She has a history of Graves disease but reports discontinuing all her medications four months ago because she felt well. Two days ago, she developed a severe sore throat, cough, and subjective fever.

Vital signs are temperature 40.1∘C40.1^\circ\text{C} (104.2∘F104.2^\circ\text{F}), blood pressure 156/64 mm Hg156/64\text{ mm Hg}, pulse 168/min168/\text{min} and irregularly irregular, and respirations 28/min28/\text{min}.

On physical examination, the patient is delirious, profusely diaphoretic, and uncooperative. She has prominent proptosis and a diffusely enlarged, non-tender thyroid gland with an audible bruit. Neuromuscular examination reveals marked hyperreflexia and a fine resting tremor. An electrocardiogram confirms atrial fibrillation with a rapid ventricular response.

Following initial airway stabilization and intravenous fluid resuscitation, arrange the following pharmacologic interventions in the required chronological sequence for the definitive management of this patient's endocrine emergency.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct chronological sequence is intravenous propranolol, followed by oral propylthiouracil, and finally oral potassium iodide.
The correct pharmacological sequence for treating thyroid storm is critical to safely downregulate the hypermetabolic state without causing an exacerbation. Propranolol is the most immediate priority to stabilize the patient's cardiovascular status and manage adrenergic symptoms such as her atrial fibrillation with rapid ventricular response. Next, a thionamide (propylthiouracil) is administered to inhibit thyroid peroxidase, thereby halting the synthesis of new thyroid hormone. Finally, an iodine solution (potassium iodide) is given to block the release of preformed hormone (the Wolff-Chaikoff effect). It is absolutely imperative that the iodine solution is administered at least 11 hour after the thionamide. If given before or concurrently, the iodine will serve as a rich substrate for the unblocked thyroid gland, leading to a massive release of new hormone and dangerous worsening of the thyroid storm (Jod-Basedow phenomenon).

Adım Adım Çözüm

1
Administer intravenous propranolol.
Blockade of peripheral beta-adrenergic receptors and decreased peripheral conversion of T4T_4 to T3T_3.
Provides immediate stabilization of cardiovascular collapse, atrial fibrillation, and severe adrenergic symptoms.
2
Administer oral propylthiouracil (PTU).
Inhibition of the enzyme thyroid peroxidase.
Halts de novo synthesis of thyroid hormone and must be fully systemic before any iodine exposure occurs.
3
Administer oral potassium iodide.
Inhibition of preformed thyroid hormone release from the gland (Wolff-Chaikoff effect).
Must be given at least 11 hour after PTU administration to prevent the paradoxical exacerbation of thyrotoxicosis.

Anahtar Kavram

In the management of thyroid storm, beta-blockers are given immediately for symptom control, followed by a thionamide to block hormone synthesis. Iodine must be delayed until at least 11 hour after thionamide administration to prevent the utilization of iodine for further hormone synthesis.
Tahmini Süre:1m 30s
Soru 1830Soru →

A 68-year-old man is hospitalized for an acute left middle cerebral artery ischemic stroke. He received thrombolytic therapy upon admission, and his neurologic deficits have now plateaued. The multidisciplinary team is initiating the discharge planning process to ensure a safe transition to a post-acute care setting. Arrange the following steps of the care transition and disposition process in the most appropriate sequential order, from initial clinical assessment to final execution.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is: Confirm medical stability, determine therapy tolerance (level of care), assess resources/bed availability, perform final medication reconciliation, and execute clinical handoff.
Safe disposition planning follows a logical progression from purely clinical parameters to logistical execution. The patient must first be medically stable. Second, their clinical and functional needs determine the required category of post-acute care (e.g., IRF vs SNF). Third, logistical factors (insurance, caregiver, bed availability) are applied to select a specific facility. Finally, the actual transition is prepared via medication reconciliation and executed via structured handoff.

Adım Adım Çözüm

1
Ascertain patient stability.
The patient is deemed medically ready for discharge from the acute care hospital.
Acute care criteria must be resolved before considering any post-acute disposition.
2
Evaluate functional needs.
The team determines whether the patient requires an IRF, SNF, or home health care.
Clinical requirements dictate the category of post-acute care setting needed.
3
Assess psychosocial and financial resources.
A specific facility within the patient's insurance network with an available bed is identified.
A theoretical disposition plan must be matched with practical, real-world availability and coverage.
4
Reconcile medications.
A finalized list of active discharge medications is prepared.
The exact regimen must be established just prior to leaving to avoid discrepancies upon arrival at the next setting.
5
Communicate the handoff.
The receiving facility is formally briefed on the patient's hospital course and pending needs.
Effective communication at the moment of transition minimizes medical errors and readmissions.

Anahtar Kavram

Standardized Safe Discharge and Care Setting Transitions
Soru 1831Soru →

An oncologist is managing a 59-year-old male with metastatic melanoma who recently completed his third cycle of pembrolizumab. The patient is admitted to the medical ward reporting 8 to 10 watery bowel movements daily, accompanied by severe abdominal cramping and trace hematochezia over the past two days. Vital signs are stable. He is clinically suspected of having severe (Grade 3) immune-mediated colitis. Arrange the following steps in the standard sequence for the diagnostic workup, therapeutic intervention, and longitudinal monitoring of this patient's condition.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence begins with ruling out infection, followed by initiating high-dose corticosteroids, evaluating response at 48 to 72 hours, escalating to a biologic if refractory, and finally completing a prolonged 4 to 6 week steroid taper upon improvement.
The correct management sequence for Grade 3 immune-mediated colitis strictly follows oncologic guidelines. Infection must first be ruled out to ensure immunosuppression is safe. Once excluded, the checkpoint inhibitor is held, and intravenous corticosteroids are given. A mandatory monitoring interval of 48 to 72 hours dictates the next step: if symptoms improve, a slow 4-6 week taper is initiated when symptoms reach Grade 1; if symptoms do not improve, the patient is deemed steroid-refractory, and a biologic such as infliximab must be administered.

Adım Adım Çözüm

1
Rule out infectious causes of acute severe diarrhea.
Stool studies for enteric pathogens and C. difficile are collected.
Empiric high-dose immunosuppression can be fatal if the underlying cause is infectious rather than autoimmune.
2
Initiate first-line immunosuppressive therapy for Grade 3 colitis.
Pembrolizumab is held and IV methylprednisolone (1-2 mg/kg/day) is administered.
High-dose systemic corticosteroids are the standard first-line treatment for severe immune-related adverse events.
3
Monitor for therapeutic efficacy over a standardized interval.
The patient is closely observed and reassessed at 48 to 72 hours.
This specific time window determines whether the immune-related adverse event is steroid-responsive or steroid-refractory.
4
Provide rescue therapy if the initial intervention fails.
Infliximab or vedolizumab is added if diarrhea frequency and abdominal pain do not improve.
Steroid-refractory cases require additional biologic immunosuppression to halt mucosal damage and systemic inflammation.
5
De-escalate therapy safely once the condition stabilizes.
Corticosteroids are transitioned to oral formulations and tapered over 4 to 6 weeks.
Rapid withdrawal of steroids in immune-mediated toxicities highly risks a flare or rebound of the immune response.

Anahtar Kavram

Monitoring and evaluation of immune-related adverse events (irAEs) requires a protocolized approach: exclude infection, begin high-dose steroids, evaluate at 48-72 hours for steroid refractoriness, escalate to biologics if necessary, and execute a 4-6 week taper to prevent rebound.
Soru 1832Soru →

A 34-year-old man presents to the clinic for a routine medical evaluation. He has no significant past medical history and takes no medications. He reports experiencing occasional muscle weakness and cramps in his legs over the past three months. His blood pressure is 168/104 mmHg168/104 \text{ mmHg} on two separate readings during the visit. His heart rate is 76/min76/\text{min}, and his body mass index is 24 kg/m224 \text{ kg/m}^2. Physical examination reveals no abdominal bruits, and peripheral pulses are normal and symmetric. Initial laboratory studies show the following:

Laboratory TestResultReference Range
Sodium144 mEq/L144 \text{ mEq/L}136−145 mEq/L136-145 \text{ mEq/L}
Potassium3.1 mEq/L3.1 \text{ mEq/L}3.5−5.0 mEq/L3.5-5.0 \text{ mEq/L}
Chloride104 mEq/L104 \text{ mEq/L}95−105 mEq/L95-105 \text{ mEq/L}
Bicarbonate29 mEq/L29 \text{ mEq/L}22−28 mEq/L22-28 \text{ mEq/L}
Creatinine0.9 mg/dL0.9 \text{ mg/dL}0.7−1.3 mg/dL0.7-1.3 \text{ mg/dL}

Which of the following is the most appropriate next step in the diagnostic workup?

Cevabı ve açıklamayı göster

Cevap: Measurement of plasma aldosterone concentration and plasma renin activity

Cevap

Measurement of plasma aldosterone concentration and plasma renin activity is the correct first step to screen for primary hyperaldosteronism.
The correct sequence for diagnosing primary hyperaldosteronism begins with demonstrating autonomous hormone production. The first, least invasive, and most sensitive step is measuring the morning plasma aldosterone concentration (PAC) and plasma renin activity (PRA). An elevated ratio indicates primary hyperaldosteronism (where aldosterone suppresses renin). Only after this screening is positive should a physician proceed to confirmatory testing (e.g., oral sodium loading, IV saline infusion) and subsequently to imaging (CT of the abdomen).

Adım Adım Çözüm

1
Analyze the patient's clinical and laboratory presentation.
The patient is a young male with severe hypertension, spontaneous hypokalemia, and mild metabolic alkalosis without any medication use.
Identifying the classic triad of hypertension, unexplained hypokalemia, and metabolic alkalosis narrows the differential diagnosis toward states of mineralocorticoid excess.
2
Determine the optimal diagnostic sequencing algorithm for suspected mineralocorticoid excess.
The initial step must distinguish between primary and secondary hyperaldosteronism using a biochemical screening test.
Screening must precede confirmatory testing (like saline infusion) or localization imaging (like CT scans) to avoid the high false-positive rates associated with adrenal incidentalomas.
3
Select the appropriate non-invasive screening modality.
The measurement of plasma aldosterone concentration (PAC) and plasma renin activity (PRA) is selected.
An elevated PAC/PRA ratio (usually > 20) with an elevated absolute aldosterone level points to a primary adrenal source (Conn's syndrome), whereas a low ratio with high renin points to a secondary source (like renal artery stenosis).

Anahtar Kavram

The diagnostic sequencing for primary hyperaldosteronism requires initial biochemical screening (PAC/PRA ratio), followed by biochemical confirmation (e.g., saline suppression test), and finally localization with cross-sectional imaging (CT abdomen).
Soru 1833Soru →

A 54-year-old man comes to the clinic to establish primary care. He has a 5-year history of type 2 diabetes mellitus, which is currently managed with metformin. He also has a 30-pack-year smoking history and continues to smoke 1 pack of cigarettes daily. The patient has not seen a physician or received any preventive care in the past 15 years. He feels well and reports no chest pain, shortness of breath, claudication, or changes in bowel habits. His blood pressure is 138/88 mm Hg, and his body mass index is 31 kg/m². Physical examination is unremarkable. Which of the following preventive interventions are currently indicated for this patient? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Low-dose computed tomography of the chest; 20-valent pneumococcal conjugate vaccine

Cevap

The indicated interventions are low-dose computed tomography of the chest and the 20-valent pneumococcal conjugate vaccine.
The patient requires low-dose computed tomography (LDCT) of the chest and the 20-valent pneumococcal conjugate vaccine (PCV20). The USPSTF recommends annual lung cancer screening with LDCT for adults aged 50 to 80 years who have a 20 pack-year or greater smoking history and currently smoke or have quit within the past 15 years. This 54-year-old patient with a 30-pack-year history clearly meets these criteria. Additionally, the Advisory Committee on Immunization Practices (ACIP) recommends pneumococcal vaccination for adults aged 19 to 64 years who have underlying medical conditions such as diabetes mellitus or who are current cigarette smokers. This patient meets both of these high-risk criteria for early pneumococcal vaccination.

Adım Adım Çözüm

1
Evaluate the patient's age and risk factors for cancer screening guidelines.
The patient is 54 years old with a 30-pack-year smoking history and currently smokes.
Age and smoking history dictate the need for lung cancer screening (LDCT starting at age 50 for >20 pack-years) and abdominal aortic aneurysm screening (US starting at age 65 for men who have ever smoked).
2
Evaluate the patient's comorbidities for immunization indications.
The patient has type 2 diabetes mellitus and is a current smoker.
Both diabetes and current smoking are independent indications for administering the pneumococcal vaccine in adults younger than 65 years.
3
Assess other screening modalities against current USPSTF recommendations.
PSA testing is not indicated before age 55, and carotid ultrasonography is not indicated for asymptomatic adults.
Applying evidence-based guidelines prevents overdiagnosis and unnecessary downstream invasive testing.

Anahtar Kavram

Application of age- and risk-factor-specific preventive screening and immunization guidelines.
Soru 1834Soru →

A 76-year-old man is evaluated on hospital day 5 regarding his discharge plan. He was admitted for severe community-acquired pneumonia complicated by sepsis, which has now resolved. He has completed his course of intravenous antibiotics and was transitioned to oral therapy yesterday. He has not required supplemental oxygen for 48 hours.

Prior to admission, he lived alone in a single-story home and was fully independent with all activities of daily living. Currently, he exhibits significant generalized deconditioning. Physical therapy evaluation indicates he requires the assistance of two people to transfer from bed to chair and can only ambulate 5 feet with a walker. The physical therapist strongly recommends a short-term stay at a skilled nursing facility (SNF) for intensive rehabilitation before returning home.

When the physician discusses this recommendation, the patient states, "I understand that I am weak and I might fall if I go home. I know the therapist thinks it is unsafe, but I hate nursing homes. I want to go to my own house today. I am willing to take the risk of falling."

The patient is alert, perfectly oriented to person, place, and time, and correctly articulates his medical situation, the proposed SNF plan, and the risks of his refusal. He has no history of psychiatric illness or dementia.

Vital signs are temperature 37.1°C (98.8°F), blood pressure 122/76 mm Hg, pulse 78/min, and respirations 14/min. Laboratory results show a blood urea nitrogen of 28 mg/dL and a serum creatinine of 1.2 mg/dL (baseline 1.0 mg/dL), both of which have steadily improved since admission.

Which of the following is the most appropriate next step in the management of this patient's disposition?

Cevabı ve açıklamayı göster

Cevap: Discharge the patient home and arrange for home health physical and occupational therapy

Cevap

Discharge the patient home and arrange for home health physical and occupational therapy.
The correct action is to discharge the patient home and arrange for home health physical and occupational therapy. This scenario highlights the intersection of disposition planning and medical ethics. The patient is medically stable and ready for discharge from the acute care hospital. While a skilled nursing facility (SNF) is the medically optimal disposition due to his deconditioning and high fall risk, the patient explicitly refuses this recommendation. To refuse medical care (including disposition recommendations), a patient must have clinical decision-making capacity, which requires the ability to understand the information, appreciate the situation and its consequences, reason through the options, and communicate a clear choice. This patient clearly demonstrates capacity by acknowledging his weakness, understanding the therapist's safety concerns, and explicitly accepting the risk of falling in order to return to his own home. Because he has capacity, the physician must respect his autonomy. The most appropriate next step is to facilitate his discharge home against medical advice (or against recommended disposition) while maximizing his safety by ordering home health services.

Adım Adım Çözüm

1
Assess the patient's medical stability for discharge.
The patient is medically stable, with normalized vital signs, improving labs, and no need for IV medications or oxygen.
Determines if acute hospital care is still physiologically required.
2
Evaluate the proposed disposition and the patient's response.
The physical therapist recommends a skilled nursing facility (SNF), but the patient explicitly refuses and wishes to go home.
Safe disposition requires either patient agreement or a legally valid alternative plan.
3
Determine if the patient possesses clinical decision-making capacity.
Capacity is fully intact; the patient communicates a clear choice, understands the medical situation, appreciates the consequences, and reasons logically about the risks (e.g., falling).
A patient with documented capacity has the ethical and legal right to refuse medical recommendations, including safe disposition planning.
4
Formulate a disposition plan that respects patient autonomy while minimizing harm.
Discharge home as requested, but order home health therapy services.
Maximizes the patient's safety within the confines of their autonomous choice.

Anahtar Kavram

Patients with intact decision-making capacity have the right to refuse medically advised care settings (like a SNF) and be discharged home, provided risks are mitigated as much as possible.
Soru 1835Soru →

During a busy shift in the emergency department, you are evaluating an 82-year-old male resident of an assisted living facility who was brought in due to increased work of breathing and a new-onset fever. Chest imaging reveals a focal consolidation in the right lower lobe, confirming a diagnosis of community-acquired pneumonia. To ensure a safe and evidence-based transition of care, arrange the following decision-making steps in the correct chronological order to determine his optimal disposition.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence begins with identifying critical illness (ICU criteria), followed by objective risk stratification (PSI/CURB-65), assessing functional capability (oral tolerance), evaluating social determinants, and finally executing the disposition plan.
The correct sequence prioritizes identifying critical illness first. A patient requiring immediate life-saving interventions (e.g., mechanical ventilation) requires ICU admission, overriding any other scores. Once ICU need is excluded, objective risk scores (PSI/CURB-65) stratify mortality risk to suggest ward versus outpatient care. However, these scores assume the patient can physically take the medication; thus, assessing functional capacity (ability to maintain oral intake) is the mandatory next step. Finally, even functionally capable patients require a safe environment; assessing social determinants ensures outpatient safety before finalizing the disposition.

Adım Adım Çözüm

1
Assess for immediate life threats requiring intensive care.
Determines if the patient requires ICU admission based on major IDSA/ATS criteria.
Prevents delayed stabilization of critically ill patients.
2
Apply objective risk stratification tools.
Uses the PSI or CURB-65 score to separate remaining patients into general ward admission versus potential outpatient care.
Provides an evidence-based estimate of 30-day mortality.
3
Evaluate functional and social barriers to outpatient care.
Identifies patients who require admission despite a low risk score due to inability to take oral medications or lack of safe home support.
Ensures the patient can practically and safely complete the treatment plan outside the hospital.

Anahtar Kavram

The step-wise clinical algorithm for determining pneumonia disposition prioritizes immediate life threats, followed by objective risk stratification, and concludes with functional and social feasibility assessments.
Soru 1836Soru →

A 4848-year-old man comes to the clinic for a routine follow-up visit. Three weeks ago, he was diagnosed with active, smear-positive pulmonary tuberculosis and was started on a daily induction regimen of isoniazid, rifampin, pyrazinamide, and ethambutol, along with pyridoxine. Today, he reports that his initial cough has significantly improved and he has not had a fever or night sweats for the past week. He feels well and specifically denies fatigue, anorexia, nausea, vomiting, dark urine, or abdominal pain. He has a history of latent tuberculosis 1515 years ago for which he did not complete treatment. He takes no other medications and does not consume alcohol. Vital signs are within normal limits. Physical examination reveals no scleral icterus, right upper quadrant tenderness, or hepatomegaly.

Laboratory studies obtained today (Week 3) compared to baseline (Week 0) are as follows:

ParameterWeek 0 (Baseline)Week 3 (Today)Reference Range
Total bilirubin0.80.8 mg/dL1.01.0 mg/dL0.10.1-1.21.2 mg/dL
Aspartate aminotransferase (AST)2222 U/L138138 U/L88-4040 U/L
Alanine aminotransferase (ALT)2828 U/L152152 U/L1010-4040 U/L
Alkaline phosphatase8585 U/L9292 U/L4040-120120 U/L

Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Continue the current medication regimen and repeat laboratory testing in one week

Cevap

Continue the current medication regimen and repeat laboratory testing in one week
The correct action is to continue the current medication regimen and monitor closely. Mild, asymptomatic elevation in hepatic transaminases is a common and expected pharmacologic effect during the initial weeks of treatment with isoniazid, rifampin, and pyrazinamide (which are all potentially hepatotoxic). According to clinical guidelines, these medications should be stopped only if transaminases rise to greater than 3 times the upper limit of normal in a patient with symptoms of clinical hepatitis (e.g., nausea, vomiting, right upper quadrant pain, jaundice, profound fatigue), or if they rise to greater than 5 times the upper limit of normal in an asymptomatic patient. This patient is completely asymptomatic, and his AST and ALT are approximately 3.5 and 3.8 times the upper limit of normal, respectively. Because the 5 times upper limit of normal threshold has not been reached, discontinuing or altering the medications is inappropriate. The best approach is careful surveillance with repeat liver chemistries in one week.

Adım Adım Çözüm

1
Analyze the patient's clinical presentation.
The patient is entirely asymptomatic, specifically denying signs of clinical hepatitis such as nausea, vomiting, abdominal pain, jaundice, and fatigue.
Determining the presence or absence of symptoms is critical for applying toxicity management algorithms.
2
Evaluate the laboratory values in the context of reference ranges.
AST is 138 U/L (approximately 3.5 times the upper limit of normal) and ALT is 152 U/L (approximately 3.8 times the upper limit of normal). Total bilirubin and alkaline phosphatase remain normal.
Quantifying the degree of transaminase elevation determines whether the toxicity threshold has been crossed.
3
Apply established monitoring guidelines for antituberculous therapy.
Guidelines dictate that hepatotoxic drugs (isoniazid, rifampin, pyrazinamide) should only be discontinued if transaminases exceed 3 times the upper limit of normal in the presence of symptoms, or if they exceed 5 times the upper limit of normal in the absence of symptoms.
These established thresholds balance the risk of severe drug-induced liver injury against the risk of tuberculosis treatment failure.
4
Determine the appropriate management intervention.
Since the patient is asymptomatic and transaminases are less than 5 times the upper limit of normal, the current regimen should be continued without alteration, accompanied by close serial monitoring.
Mild, asymptomatic transaminitis is a common and often transient expected effect of induction therapy.

Anahtar Kavram

Management of antituberculous drug-induced hepatotoxicity based on symptom correlation and enzymatic thresholds.
Soru 1837Soru →

A 6767-year-old woman with a mechanical aortic valve is brought to the emergency department by her daughter due to vomiting dark blood and passing black, tarry stools for the past 1212 hours. She was prescribed ciprofloxacin 55 days ago for an uncomplicated urinary tract infection. Her home medications include warfarin and low-dose aspirin.

Temperature is 36.8∘C36.8^\circ\text{C} (98.2∘F98.2^\circ\text{F}), blood pressure is 84/52 mmHg84/52\text{ mmHg}, heart rate is 122/min122/\text{min}, and respiratory rate is 22/min22/\text{min}. She is lethargic and pale.

Laboratory studies show:

TestResult
Hemoglobin6.8 g/dL6.8\text{ g/dL}
Platelet count165,000/mm3165,000/\text{mm}^3
Prothrombin time (PT)52 seconds52\text{ seconds}
INR5.25.2
Partial thromboplastin time (PTT)32 seconds32\text{ seconds}

Two large-bore intravenous lines are established, and rapid infusion of isotonic crystalloids and packed red blood cells is initiated. Which of the following is the most appropriate next step in pharmacologic management?

Cevabı ve açıklamayı göster

Cevap: Intravenous 4-factor prothrombin complex concentrate (PCC) and intravenous vitamin K

Cevap

Intravenous 4-factor prothrombin complex concentrate (PCC) and intravenous vitamin K
The patient is experiencing life-threatening gastrointestinal hemorrhage complicated by hemorrhagic shock and supratherapeutic anticoagulation. The elevated INR is a result of a drug-drug interaction between warfarin and ciprofloxacin (a CYP450 inhibitor). For patients on warfarin presenting with major, life-threatening bleeding, the standard of care is immediate and rapid reversal of anticoagulation. The preferred agent is 4-factor prothrombin complex concentrate (PCC) because it contains concentrated forms of the vitamin K-dependent factors (II, VII, IX, X) and can be administered rapidly in a small volume. Intravenous vitamin K must be administered concurrently because the half-lives of the factors in PCC are relatively short; vitamin K promotes the endogenous hepatic synthesis of these factors to maintain long-term hemostasis.

Adım Adım Çözüm

1
Assess the patient's hemodynamic status and clinical presentation.
The patient is in hemorrhagic shock (hypotension, tachycardia, lethargy, low hemoglobin) secondary to severe upper gastrointestinal bleeding.
Identifying life-threatening instability dictates that immediate resuscitation and rapid pharmacologic reversal take precedence over observation or slow-acting therapies.
2
Interpret the laboratory results in the context of the patient's recent medication changes.
The INR is critically elevated at 5.25.2. This is due to ciprofloxacin inhibiting cytochrome P450 enzymes (CYP1A2 and CYP3A4), which decreased warfarin metabolism and led to supratherapeutic anticoagulation.
Understanding the pharmacokinetic etiology confirms that the coagulopathy is strictly due to vitamin K-dependent factor depletion.
3
Select the most appropriate pharmacologic reversal strategy for warfarin in a life-threatening bleeding scenario.
4-factor prothrombin complex concentrate (PCC) combined with intravenous vitamin K is the standard of care.
PCC rapidly replenishes factors II, VII, IX, and X in a small fluid volume, while IV vitamin K promotes sustained endogenous hepatic synthesis of these factors after the exogenous PCC degrades.

Anahtar Kavram

Urgent reversal of warfarin-induced coagulopathy in life-threatening bleeding using 4-factor PCC and IV vitamin K.
Tahmini Süre:1m 30s
Soru 1838Soru →

A 79-year-old woman is brought to the emergency department by a neighbor for evaluation of a new-onset productive cough and subjective fevers over the past two days. Her medical history is notable for hypertension, mild cognitive impairment, and osteoarthritis of the knees. Vital signs reveal a temperature of 37.8°C (100.0°F), blood pressure of 135/82 mmHg, heart rate of 88/min, and respiratory rate of 18/min. Oxygen saturation is 96% on ambient air. Laboratory results demonstrate a blood urea nitrogen level of 16 mg/dL and a normal complete blood count. A chest radiograph reveals a patchy infiltrate in the left lower lobe, consistent with community-acquired pneumonia. Her calculated Pneumonia Severity Index (PSI) score is 69 (Risk Class II) and her CURB-65 score is 1.

During the clinical evaluation, the patient appears frail and has significant difficulty standing from the stretcher. The neighbor reports that the patient lives alone in a multi-level house and has experienced two unprovoked falls in the past week due to generalized weakness. She currently requires physical assistance with toileting and meal preparation, but her usual part-time caregiver is out of the country for the next month.

Based on the synthesis of her objective risk scores and functional status, which of the following is the most appropriate disposition for this patient?

Cevabı ve açıklamayı göster

Cevap: Admit to the acute care inpatient medical ward for treatment and multidisciplinary evaluation

Cevap

Admit to the acute care inpatient medical ward for treatment and multidisciplinary evaluation
The most appropriate disposition is admitting the patient to the acute care inpatient medical ward. When determining disposition for community-acquired pneumonia, clinicians must synthesize objective severity scores (such as the PSI and CURB-65) with subjective functional and social factors. While a PSI of 69 (Class II) and a CURB-65 of 1 typically indicate a low risk of mortality and medical suitability for outpatient treatment, this patient exhibits acute-on-chronic functional decline, an inability to independently perform activities of daily living (ADLs), a high fall risk, and an absent caregiver. Clinical guidelines mandate hospital admission for patients who lack the necessary social support or functional capacity to safely manage their illness at home, regardless of low objective risk scores. An inpatient admission provides a safe environment to administer therapy, stabilize her medical condition, and allow physical, occupational, and social work teams to coordinate a safe post-discharge transition.

Adım Adım Çözüm

1
Evaluate the patient's medical severity using objective scoring systems.
The PSI score of 69 (Class II) and CURB-65 score of 1 indicate a low short-term mortality risk.
Objective risk stratification is the first step in determining the appropriate level of care for community-acquired pneumonia.
2
Assess the patient's functional capacity and social support system.
The patient is frail, has had recent falls, requires assistance with basic ADLs, and her caregiver is unavailable.
Functional and social factors can override objective medical scores when determining safe disposition.
3
Determine the safest and most appropriate disposition setting.
The patient must be admitted to the inpatient medical ward.
Discharging a functionally impaired patient to an unsupported home environment is unsafe; she requires multidisciplinary evaluation before transitioning to a post-acute care facility.

Anahtar Kavram

In patients with acute illnesses like community-acquired pneumonia, poor functional capacity and lack of social support dictate the need for inpatient admission, even when objective severity scores suggest a low medical risk.
Tahmini Süre:1m 15s
Soru 1839Soru →

Match each clinical scenario involving suspected venous thromboembolism to the most appropriate next step in the diagnostic test sequence based on current clinical guidelines.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A patient with a high pre-test probability for pulmonary embolism, a normal serum creatinine level, and no known drug allergies.
A patient with a low pre-test probability for pulmonary embolism presenting with acute pleuritic chest pain and a normal baseline chest radiograph.
A pregnant patient in her second trimester with acute dyspnea, pleuritic chest pain, and a newly swollen, tender left calf.
A patient with a high pre-test probability for pulmonary embolism who has stage 4 chronic kidney disease and a documented history of anaphylaxis to iodinated contrast media.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

High pre-test probability matches with CTPA. Low pre-test probability matches with D-dimer assay. Pregnant patient with a swollen calf matches with lower extremity ultrasonography. High pre-test probability with severe chronic kidney disease and contrast allergy matches with V/Q scan.
The correct matches reflect standard evidence-based algorithms for the diagnostic workup of suspected venous thromboembolism, optimizing diagnostic yield while minimizing patient harm from radiation and contrast.

Adım Adım Çözüm

1
Evaluate the clinical pre-test probability and contraindications for the first scenario.
The patient has a high probability of pulmonary embolism without contraindications.
Risk stratification dictates that high-probability patients proceed directly to definitive imaging with CTPA.
2
Assess the pre-test probability for the second scenario.
The patient has a low probability of pulmonary embolism.
Clinical guidelines recommend using a D-dimer assay to rule out pulmonary embolism in low-risk patients, avoiding unnecessary imaging.
3
Identify special populations and accompanying symptoms in the third scenario.
The pregnant patient has symptoms suggestive of deep vein thrombosis in addition to dyspnea.
Diagnostic algorithms in pregnancy prioritize non-radiation tests; a positive compression ultrasound confirms venous thromboembolism and directs therapy without the need for immediate chest imaging.
4
Analyze contraindications in the fourth scenario.
The patient has severe chronic kidney disease and a contrast allergy.
CTPA is contraindicated due to contrast administration; a V/Q scan provides necessary diagnostic imaging without iodinated contrast.

Anahtar Kavram

Appropriate test sequencing for suspected pulmonary embolism depends heavily on clinical pre-test probability, pregnancy status, concurrent symptoms of deep vein thrombosis, and contraindications to contrast media.
Tahmini Süre:1m 30s
Soru 1840Soru →

During a routine follow-up appointment, a physician evaluates a female patient who reports 33 weeks of progressive exertional dyspnea, orthopnea, and lower extremity swelling. The patient is 6868 years old and has a past medical history significant for type 22 diabetes mellitus, essential hypertension, and osteoarthritis. Her home medication regimen consists of metformin, pioglitazone, lisinopril, amlodipine, and daily naproxen.

On physical examination, her blood pressure is 145/88 mmHg145/88\text{ mmHg}, heart rate is 86/min86/\text{min}, and respiratory rate is 18/min18/\text{min}. Jugular venous distention is present at 8 cm8\text{ cm} above the sternal angle. Auscultation of the lungs reveals fine bibasilar crackles. The lower extremities exhibit 2+2+ bilateral pitting edema. A comprehensive metabolic panel is unremarkable, with a serum creatinine of 1.1 mg/dL1.1\text{ mg/dL}. A recent transthoracic echocardiogram demonstrates a left ventricular ejection fraction of 32%32\% with global hypokinesis.

Based on the current clinical findings and medication profile, which of the following pharmacologic interventions are appropriate for this patient? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Discontinue pioglitazone; Discontinue naproxen; Initiate oral furosemide

Cevap

The correct interventions are to discontinue pioglitazone, discontinue naproxen, and initiate oral furosemide.
This patient presents with new-onset symptomatic heart failure with reduced ejection fraction (HFrEF) accompanied by significant volume overload. Optimal management requires simultaneous medication reconciliation and initiation of symptom-relieving therapy. Pioglitazone (a thiazolidinedione) causes fluid retention by acting on the renal collecting ducts and is contraindicated in symptomatic heart failure. Naproxen (an NSAID) inhibits prostaglandins, reducing renal blood flow and promoting sodium retention, which blunts diuretic efficacy and worsens congestion. Both must be discontinued. Concurrently, a loop diuretic such as oral furosemide must be initiated to effectively manage her hypervolemia and relieve her dyspnea and edema.

Adım Adım Çözüm

1
Identify the primary clinical problem and its severity.
The patient has newly diagnosed heart failure with reduced ejection fraction (HFrEF) presenting with overt volume overload.
Symptoms of exertional dyspnea and orthopnea, signs of elevated JVD, crackles, and edema, combined with an ejection fraction of 32% confirm decompensated HFrEF.
2
Evaluate the current medication list for agents that exacerbate heart failure.
Pioglitazone and naproxen are identified as harmful in this setting.
Both medications independently promote sodium and water retention, which directly worsens pulmonary and systemic congestion.
3
Determine the necessary pharmacologic additions for acute symptom management.
A loop diuretic, such as oral furosemide, must be added.
The patient has significant clinical signs of fluid overload that require prompt diuresis to relieve symptoms and restore euvolemia.
4
Review remaining interventions for appropriateness regarding HFrEF contraindications.
Metformin should be continued, and non-dihydropyridine calcium channel blockers (like diltiazem) should be avoided.
Metformin is safe in HF without severe renal impairment. Non-DHP CCBs are contraindicated due to negative inotropic effects that can further compromise cardiac output.

Anahtar Kavram

Medication reconciliation in newly diagnosed HFrEF requires discontinuing fluid-retaining agents (NSAIDs, TZDs) and avoiding negative inotropes (non-DHP CCBs), while promptly initiating loop diuretics for volume overload.
ÖncekiSayfa 92 / 104Sonraki
Patient Management Alıştırma Soruları — USMLE Step 3 — Sayfa 92 | Examkin